Pfizer PGN 225
Generic Name: pregabalin
Pill imprint Pfizer PGN 225 has been identified as Lyrica 225 mg.
Lyrica is used in the treatment of fibromyalgia; persisting pain, shingles; diabetic nerve damage; epilepsy; spondylolisthesis and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy.
Lyrica 225 mg has a low potential for abuse. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 4.
See also related documents.
Lyrica Images
- Generic Name:
- pregabalin
- Imprint:
-
Pfizer
PGN 225 - Strength:
- 225 mg
- Color:
- Orange & White
- Size:
- 19.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose monohydrate
corn starch
magnesium silicate
gelatin
titanium dioxide
sodium lauryl sulfate
silicon dioxide
ferric oxide red
shellac
ferrosoferric oxide
propylene glycol
potassium hydroxide
- Drug Class:
- Gamma-aminobutyric acid analogs
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 5 - Some potential for abuse
- Manufacturer:
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- 00071-1019
| NDC Code | Manufacturer / Repackager |
|---|---|
| 16590-0733 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.


